
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 14.290 | 14.290 | 0.000 |
Shares | 87.810 | 87.810 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.051 | 24.124 |
Price to Book | 2.146 | 3.013 |
Price to Sales | 0.962 | 3.867 |
Price to Cash Flow | 11.966 | 15.880 |
Dividend Yield | 3.099 | 1.889 |
5 Years Earnings Growth | 10.430 | 13.292 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.380 | 95.436 |
Consumer Cyclical | 2.620 | 1.238 |
Number of long holdings: 43
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shenzhen Mindray Bio-Medical | CNE100003G67 | 9.89 | 236.66 | +1.14% | |
Jiangsu Hengrui | CNE0000014W7 | 8.51 | 51.80 | +5.28% | |
Jointown Pharm | CNE100000W45 | 7.23 | 5.12 | +1.59% | |
Humanwell Healthcare | CNE000000QW6 | 5.99 | 21.50 | +4.37% | |
Shenzhen YHLO Biotech Co | CNE100005204 | 5.14 | 16.61 | +2.91% | |
WuXi AppTec | CNE1000031K4 | 4.83 | 68.23 | +1.35% | |
Nhwa Pharma A | CNE100000CG8 | 4.27 | 22.70 | +1.70% | |
New Industries | CNE100003T39 | 2.93 | 59.97 | +3.01% | |
Chongqing Zhifei Bio Products | CNE100000V20 | 2.72 | 25.50 | +5.07% | |
Yunnan Baiyao A | CNE0000008X7 | 2.58 | 57.07 | +0.48% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Morgan Stanley Huaxin Multiple Fact | 583.16M | 2.21 | -5.12 | 4.17 | ||
MS Huaxin Resource Selected Mixed | 417.95M | 0.58 | -14.15 | 2.66 | ||
MS Huaxin Aggressive Growth Equity | 346.35M | 2.39 | -9.07 | 4.98 | ||
Huaxin Leading Advanced Stock | 316.65M | 6.01 | -6.14 | 7.62 | ||
Huaxin Excellent Growth Stock | 260.61M | 1.02 | -13.12 | 4.23 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review